81 related articles for article (PubMed ID: 18440882)
1. LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas.
Sivak WN; Pollack IF; Petoud S; Zamboni WC; Zhang J; Beckman EJ
Acta Biomater; 2008 Jul; 4(4):852-62. PubMed ID: 18440882
[TBL] [Abstract][Full Text] [Related]
2. Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profiles.
Sivak WN; Pollack IF; Petoud S; Zamboni WC; Zhang J; Beckman EJ
Acta Biomater; 2008 Sep; 4(5):1263-74. PubMed ID: 18440884
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous drug release at different rates from biodegradable polyurethane foams.
Sivak WN; Zhang J; Petoud S; Beckman EJ
Acta Biomater; 2009 Sep; 5(7):2398-408. PubMed ID: 19398389
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of ionic ligands accelerates drug release from LDI-glycerol polyurethanes.
Sivak WN; Zhang J; Petoud S; Beckman EJ
Acta Biomater; 2010 Jan; 6(1):144-53. PubMed ID: 19524075
[TBL] [Abstract][Full Text] [Related]
5. Degradative-release as a function of drug structure from LDI-glycerol polyurethanes.
Sivak WN; Zhang J; Petoud S; Beckman EJ
Biomed Mater Eng; 2010; 20(5):269-81. PubMed ID: 21084739
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable and temperature-responsive polyurethanes for adriamycin delivery.
Sun X; Gao H; Wu G; Wang Y; Fan Y; Ma J
Int J Pharm; 2011 Jun; 412(1-2):52-8. PubMed ID: 21511019
[TBL] [Abstract][Full Text] [Related]
7. The effect of DB-67, a lipophilic camptothecin derivative, on topoisomerase I levels in non-small-cell lung cancer cells.
Bence AK; Mattingly CA; Burke TG; Adams VR
Cancer Chemother Pharmacol; 2004 Oct; 54(4):354-60. PubMed ID: 15197485
[TBL] [Abstract][Full Text] [Related]
8. A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering.
Zhang J; Doll BA; Beckman EJ; Hollinger JO
J Biomed Mater Res A; 2003 Nov; 67(2):389-400. PubMed ID: 14566779
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of biocompatible segmented polyurethanes from aliphatic diisocyanates and diurea diol chain extenders.
Guelcher SA; Gallagher KM; Didier JE; Klinedinst DB; Doctor JS; Goldstein AS; Wilkes GL; Beckman EJ; Hollinger JO
Acta Biomater; 2005 Jul; 1(4):471-84. PubMed ID: 16701828
[TBL] [Abstract][Full Text] [Related]
10. A new peptide-based urethane polymer: synthesis, biodegradation, and potential to support cell growth in vitro.
Zhang JY; Beckman EJ; Piesco NP; Agarwal S
Biomaterials; 2000 Jun; 21(12):1247-58. PubMed ID: 10811306
[TBL] [Abstract][Full Text] [Related]
11. The comparison of biophysical properties of DB-67 and its ester DB-67-4ABTFA determined by fluorescence spectroscopy methods.
Kruszewski S; Ziomkowska B; Cyrankiewicz M; Wybranowski T
Biosystems; 2008 Dec; 94(3):270-5. PubMed ID: 18718502
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of dexamethasone acetate from biodegradable and biocompatible polyurethane and polyurethane nanocomposite.
Da Silva GR; Ayres E; Orefice RL; Moura SA; Cara DC; Cunha Ada S
J Drug Target; 2009 Jun; 17(5):374-83. PubMed ID: 19555266
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.
Ranganath SH; Wang CH
Biomaterials; 2008 Jul; 29(20):2996-3003. PubMed ID: 18423584
[TBL] [Abstract][Full Text] [Related]
14. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
15. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity.
Bom D; Curran DP; Zhang J; Zimmer SG; Bevins R; Kruszewski S; Howe JN; Bingcang A; Latus LJ; Burke TG
J Control Release; 2001 Jul; 74(1-3):325-33. PubMed ID: 11489514
[TBL] [Abstract][Full Text] [Related]
16. In-vitro and in-vivo antibacterial activity evaluation of a polyurethane matrix.
Lee SH; Kim SR; Kim JS; Bae HR; Lee CH; Kim DD
J Pharm Pharmacol; 2003 Apr; 55(4):559-66. PubMed ID: 12803779
[TBL] [Abstract][Full Text] [Related]
17. The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity.
Bom D; Curran DP; Kruszewski S; Zimmer SG; Thompson Strode J; Kohlhagen G; Du W; Chavan AJ; Fraley KA; Bingcang AL; Latus LJ; Pommier Y; Burke TG
J Med Chem; 2000 Oct; 43(21):3970-80. PubMed ID: 11052802
[TBL] [Abstract][Full Text] [Related]
18. CKD-602, a camptothecin derivative, inhibits proliferation and induces apoptosis in glioma cell lines.
Kim YY; Park CK; Kim SK; Phi JH; Kim JH; Kim CY; Wang KC; Cho BK
Oncol Rep; 2009 Jun; 21(6):1413-9. PubMed ID: 19424618
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticles.
Crisante F; Francolini I; Bellusci M; Martinelli A; D'Ilario L; Piozzi A
Eur J Pharm Sci; 2009 Mar; 36(4-5):555-64. PubMed ID: 19136061
[TBL] [Abstract][Full Text] [Related]
20. Biological stability of polyurethane modified with covalent attachment of di-tert-butyl-phenol.
Stachelek SJ; Alferiev I; Fulmer J; Ischiropoulos H; Levy RJ
J Biomed Mater Res A; 2007 Sep; 82(4):1004-11. PubMed ID: 17370325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
